Advanced search
Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Email Registration
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
  1. Homepage
  2. Equities
  3. China
  4. Shanghai Stock Exchange
  5. Shanghai MicroPort Endovascular MedTech Co., Ltd.
  6. News
  7. Summary
    688016   CNE100003MJ5

SHANGHAI MICROPORT ENDOVASCULAR MEDTECH CO., LTD.

(688016)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisionsFunds 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

Shanghai MicroPort Endovascular MedTech : Sees Up to 56% Surge in H1 Profit; Shares Tumble 10%

07/20/2021 | 03:31am EDT
share with twitter
share with LinkedIn
share with facebook


© MT Newswires 2021
Stocks mentioned in the article
ChangeLast1st jan.
MICROPORT SCIENTIFIC CORPORATION 0.96% 21.15 Delayed Quote.-4.91%
SHANGHAI MICROPORT ENDOVASCULAR MEDTECH CO., LTD. -1.28% 187.76 End-of-day quote.-0.68%
All news about SHANGHAI MICROPORT ENDOVASCULAR MEDTECH CO., LTD.
02/27Shanghai MicroPort Endovascular MedTech Co., Ltd. Reports Earnings Results for the Full..
CI
01/20Shanghai MicroPort Endovascular MedTech Co., Ltd. Provides Earnings Guidance for the Ye..
CI
2022Shanghai Hongmai Medical Technology Co., Ltd. announced that it expects to receive CNY ..
CI
2022Shanghai MicroPort Endovascular MedTech Co., Ltd.(S..
CI
2022Shanghai MicroPort Endovascular MedTech Co., Ltd. Reports Earnings Results for the Nine..
CI
2022Shanghai MicroPort Endovascular MedTech Sees Q3 Profit Jump 31.5%
MT
2022Shanghai MicroPort Endovascular MedTech Co., Ltd.(X..
CI
2022Shanghai MicroPort Endovascular MedTech Co., Ltd. Reports Earnings Results for the Half..
CI
2022MicroPort Scientific Unit to Issue A Shares
MT
2022Shanghai MicroPort Endovascular MedTech Co., Ltd. announced that it expects to receive ..
CI
More news
Analyst Recommendations on SHANGHAI MICROPORT ENDOVASCULAR MEDTECH CO., LTD.
More recommendations
Financials
Sales 2022 917 M 133 M 133 M
Net income 2022 393 M 57,1 M 57,1 M
Net cash 2022 1 309 M 190 M 190 M
P/E ratio 2022 34,4x
Yield 2022 0,53%
Capitalization 13 515 M 1 965 M 1 965 M
EV / Sales 2022 13,3x
EV / Sales 2023 9,54x
Nbr of Employees 660
Free-Float 51,3%
Chart SHANGHAI MICROPORT ENDOVASCULAR MEDTECH CO., LTD.
Duration : Period :
Shanghai MicroPort Endovascular MedTech Co., Ltd. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends SHANGHAI MICROPORT ENDOVASCULAR MEDTECH CO., LTD.
Short TermMid-TermLong Term
TrendsBearishNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 5
Last Close Price 187,76 CNY
Average target price 260,00 CNY
Spread / Average Target 38,5%
EPS Revisions
Managers and Directors
Qing Zhu General Manager & Director
Chun Fang Li Chief Financial Officer
Bo Peng Chairman
Cheng Yun Yue Chairman-Supervisory Board
Bao Lin Liu Independent Director
Sector and Competitors
1st jan.Capi. (M$)
SHANGHAI MICROPORT ENDOVASCULAR MEDTECH CO., LTD.-0.68%1 991
STRYKER CORPORATION13.23%104 872
IMEIK TECHNOLOGY DEVELOPMENT CO.,LTD.-8.89%15 861
SMITH & NEPHEW PLC4.69%12 447
INSPIRE MEDICAL SYSTEMS, INC.-1.51%7 227
AXONICS, INC.-5.31%2 958